Home Executives


Medtech Industry Veteran Hooman C. Hakami New Chairman of PathMaker Neurosystems BOD

Mr. Hakami is currently the Managing Director of Hakami Healthcare Advisors, LLC where he provides advisory services to Boards and CEOs in the healthcare space. Previously, he was with Medtronic, where he served as Executive Vice President and President of the Diabetes Group.

James Brown, Ph.D. Appointed President of Research Grade Nucleic Acids Aldevron Business Unit

Dr. Brown will oversee Aldevron’s strategy to provide plasmids and other nucleic acids for research and preclinical applications. He will also collaborate with Aldevron’s other business units, including GMP nucleic acids, to ensure clients benefit from the company’s full spectrum of capabilities.

Jennifer Young Joins icometrix As CEO

Jennifer brings over 20 years of experience in the radiology, medical device, and healthcare services business spanning the provider, employer and payer markets.

Drew Mellan New Director of Account Management of Noble

In this new position, Drew Mellan will serve as the voice of the customer, communicating their goals and interests to Noble with the purpose of maximizing value for them.

Dr. Peter Meintjes joins Transplant Genomics as CCO

Dr. Meintjes joins TGI after six years at Omixon, a world leader in pre-transplant HLA Typing, where he departs as CEO, having grown the company at a CAGR of >75% since its first full year of operation as a molecular diagnostics company.

Orchestra BioMed™ Enhances Management Team with Appointment of Regulatory Affairs and Combination Product Expert Bob Laughner as Vice President, Regulatory Affairs

Bob Laughner will play a lead role in advancing Orchestra BioMed’s Virtue® Sirolimus AngioInfusion™ Balloon (SAB) through global regulatory approvals.

Dr. Efthymios N. Deliargyris Appointed New CMO of Cytosorbents

Dr. Efthymios N. Deliargyris clinical expertise spans all aspects of critical care medicine and cardiovascular disease.

John Murphy Appointed GTX Medical BV Chief Technology Officer

Dr. John Murphy joins the company with over twenty years of experience in Class I, II, and III medical devices and implantables and has been instrumental in bringing numerous new devices to commercialization.